Lucy Scientific Discovery Inc. (LSDIF) vs Petros Pharmaceuticals, Inc. (PTPI)

Lucy Scientific Discovery Inc. and Petros Pharmaceuticals, Inc. are both Drug Manufacturers Specialty & Generic companies. Petros Pharmaceuticals, Inc. is the larger, with a market value of $1.0M against $900.0K — 1.2× the size. Across the 6 metrics below, Lucy Scientific Discovery Inc. leads on 3 and Petros Pharmaceuticals, Inc. on 3.

Valuation

Metric LSDIF PTPI Drug Manufacturers Specialty & Generic median
P/E n/m n/m 20.14
P/S n/m n/m 2.25
P/B n/m n/m 1.90
Price to free cash flow n/m n/m 16.54
EV/EBITDA n/m n/m 12.29
EV/Sales n/m 0.34 2.56
Earnings yield 0.00% 0.00% (2.99%)
Free cash flow yield 0.00% 0.00% 0.00%

Profitability

Metric LSDIF PTPI Drug Manufacturers Specialty & Generic median
Gross margin 0.00% 76.35% 53.94%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 337.20% (710.28%) (0.40%)
Return on assets (249.36%) (334.15%) (3.32%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric LSDIF PTPI Drug Manufacturers Specialty & Generic median
Revenue growth (TTM) — 36.07% 10.01%
EPS growth (last fiscal year) (4.46%) 98.13% —
Revenue growth, 5-year CAGR — (19.98%) 6.74%
Net income growth, 5-year CAGR — 0.00% 0.00%

Health

Metric LSDIF PTPI Drug Manufacturers Specialty & Generic median
Debt to equity 0.00 0.00 0.05
Current ratio 0.38 1.25 2.31
Net debt to EBITDA 0.05 1.11 0.85

Dividend

Metric LSDIF PTPI Drug Manufacturers Specialty & Generic median
Dividend yield — — 1.70%
Payout ratio — 0.00 0.00

Size

Metric LSDIF PTPI Drug Manufacturers Specialty & Generic median
Market cap 900.00k 1.04m 337.35m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack